|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$69,250.22 |
2.15% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$68,504.25 |
2.13% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$68,390.26 |
2.12% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$68,137.44 |
2.12% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$68,195.64 |
2.12% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$67,970.00 |
2.11% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$68,066.46 |
2.11% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$67,691.61 |
2.10% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$67,721.14 |
2.10% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$67,573.66 |
2.10% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$67,339.38 |
2.09% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$67,203.50 |
2.09% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$67,131.64 |
2.08% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$67,134.57 |
2.08% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$67,079.02 |
2.08% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$66,930.00 |
2.08% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$66,729.00 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$66,650.64 |
2.07% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$66,740.30 |
2.07% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$66,649.73 |
2.07% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$66,245.44 |
2.06% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$66,410.56 |
2.06% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$66,451.83 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$66,513.89 |
2.06% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,433.66 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
298 |
$66,352.68 |
2.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$65,994.88 |
2.05% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$65,740.47 |
2.04% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$65,390.40 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$65,468.34 |
2.03% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$65,383.60 |
2.03% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$65,450.28 |
2.03% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$65,036.60 |
2.02% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$64,934.46 |
2.02% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,863.75 |
2.01% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$64,813.52 |
2.01% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$64,466.88 |
2.00% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$64,431.70 |
2.00% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$64,437.60 |
2.00% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$64,090.26 |
1.99% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,172.00 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
147 |
$64,231.65 |
1.99% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$63,671.31 |
1.98% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$63,345.60 |
1.97% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$62,701.95 |
1.95% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$61,897.50 |
1.92% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$59,225.23 |
1.84% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$53,483.13 |
1.66% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,530.39 |
1.38% |
| US Dollar |
$USD |
|
24,365 |
$24,365.40 |
0.76% |
| Danish Krone |
$DKK |
|
0 |
$0.00 |
0.00% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| Swiss Franc |
$CHF |
|
0 |
$0.00 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|